AZGP1 and metabolic dysfunction-associated steatotic liver disease: In cancer cells, eIF2B-mediated translational reprogramming protects cancer cells from apoptosis.58,59 LV108 restored the expression of ZAG and eIF2B, reducing the risk of continued development of NAFLD.